HC009

HC009 is an investigational orally administered traditional Chinese medicine and natural-drug preparation being developed by Beijing Houcheng Medical Technology for diminished ovarian reserve with the traditional Chinese medicine pattern of kidney deficiency and liver stagnation. In China trial CTR20254996, HC009 oral solution is being evaluated in a randomized, double-blind, dose-exploration, parallel-controlled, multicenter Phase II study assessing efficacy, safety, and optimal dose. Public trial information does not disclose its active constituents, molecular targets, or molecular mechanism of action. ([chinadrugtrials.org.cn](https://www.chinadrugtrials.org.cn/clinicaltrials.searchlist.dhtml?keywords=CTR20254996))

Other names

HC-009 oral solutionHC009 oral solutionHC 009 oral solutionHC009合剂